SBI Securities’s Ensysce Biosciences ENSC Stock Holding History

SBI Securities’s Portfolio ENSC Stock Details ENSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186	Buy	641 +155	+32%	+$56	﹤0.01%	3349
2026 Q1	$262	Buy	486 +65	+15%	+$41	﹤0.01%	3121
2025 Q4	$387	Buy	421 +3	+0.7%	+$6	﹤0.01%	2968
2025 Q3	$991	Sell	418 -1,918	-82%	-$4.13K	﹤0.01%	2695
2025 Q2	$5.21K	Buy	+2,336	New	+$5.35K	﹤0.01%	1970

Other funds holding ENSC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities's ENSC Position: Q2 2026 in Review

SBI Securities increased its Ensysce Biosciences (ENSC) stake by 32% in Q2 2026, buying an estimated $56 and bringing the position to 641 shares worth $186. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

SBI Securities first reported a position in ENSC in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.21K in Q2 2025. 3 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

SBI Securities held 641 shares of Ensysce Biosciences worth $186 as of Q2 2026.
SBI Securities bought 155 Ensysce Biosciences shares in Q2 2026, an estimated $56.
Ensysce Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3349 holding.
SBI Securities first reported a position in Ensysce Biosciences in Q2 2025 and has held it in 5 quarters since.
SBI Securities's Ensysce Biosciences position peaked at $5.21K in Q2 2025.
3 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.